SCISPARC LTD (SPRC) Stock Price, Quote, News and Overview
NASDAQ:SPRC - Nasdaq - IL0010951403 - Common Stock
SPRC Quote and Key Statistics
SCISPARC LTD
NASDAQ:SPRC (1/22/2025, 8:00:02 PM)
After market: 0.59 +0.01 (+1.22%)0.5829
+0.04 (+8.06%)
SPRC Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -46.15% | ||
| ROE | -67.77% | ||
| Debt/Equity | 0 |
SPRC Performance and Technical Analysis
SPRC Ownership and Analysts
SPRC Latest News and Analysis
Friday's session: gap up and gap down stocks
Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session.
Top movers in Monday's after hours session
Which stocks are moving after the closing bell on Monday?
SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
No Immediate Effect on Nasdaq Listing or Trading of the Company’s Ordinary Shares TEL AVIV, Israel, Jan. 15, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd....
About SPRC
Company Profile
SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
Company Info
SCISPARC LTD
20 Raul Wallenberg Street, Tower A
TEL AVIV-YAFO IL
Employees: 3
Company Website: https://scisparc.com/
Investor Relations: https://investor.scisparc.com/
Phone: 97236103100
SPRC Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 74.14 | 715.77B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 27.22 | 357.84B | ||
| JNJ | JOHNSON & JOHNSON | 14.19 | 349.75B | ||
| MRK | MERCK & CO. INC. | 16.08 | 242.04B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 17.9 | 211.49B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.16 | 196.27B | ||
| PFE | PFIZER INC | 10.08 | 147.40B | ||
| SNY | SANOFI-ADR | 12.38 | 129.15B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.79 | 115.79B | ||
| ZTS | ZOETIS INC | 28.93 | 75.18B | ||
| GSK | GSK PLC-SPON ADR | 8.17 | 68.21B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 21.48 | 40.87B |